Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesPsoriatic arthritis assessment and treatment update
Current Opinion in Rheumatology, 06/15/09
Mease PJ - Increasingly, PsA is being recognized as a distinct disease entity worthy of research regarding reliable assessment and focus on the development of effective and well tolerated therapies. A number of emerging treatments, predominantly biologics, have shown substantial efficacy and reasonable safety profiles in the treatment of multiple clinical domains of PsA, thus providing the option of either monotherapy or combination therapy approaches to disease treatment.
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
The use of complementary and alternative medicine in outpatients with inflammatory rheumatic diseases in Sweden
Scandinavian Journal of Rheumatology , 11/17/09
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
Sponsor
Article Search
Sponsor